Exchange Announcement • 10 Nov 2022 15:00
Q3 2022
Exchange Announcement • 29 Jul 2022 14:00
Q2 2022
Exchange Announcement • 29 Apr 2022 19:05
Q1 2022
Exchange Announcement • 10 Feb 2022 08:00
Q4 2021
Exchange Announcement • 12 Nov 2021 08:00
𝛼SK or SearchENTITY
AstraZeneca (AZN SS)
AstraZeneca (AZN SS)
33
Analysis
Health Care • United Kingdom
AstraZeneca PLC is a Swedish-British multinational pharmaceutical and biotechnology company focused on the discovery, development, manufacture, and commercialization of prescription medicines. The company specializes in therapeutic areas including oncology, cardiovascular, renal and metabolism, respiratory and immunology, rare diseases, and vaccines. AstraZeneca was founded in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group PLC, and its headquarters are located in Cambridge, UK.
morex